Sentence: Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer : a safety , feasibility , and efficacy study from the Hoosier Oncology Group .
Drug combination annotation:
[{'class': 'NEG', 'spans': ['Paclitaxel', 'bevacizumab'], 'is_context_needed': True}]